SMS Pharmaceuticals Limited (BOM:532815)
249.95
-3.95 (-1.56%)
At close: Jun 5, 2025
SMS Pharmaceuticals Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 415.86 | 360.4 | 73.08 | 465.83 | 404.23 | Upgrade
|
Short-Term Investments | - | 0.77 | 0.7 | - | - | Upgrade
|
Cash & Short-Term Investments | 415.86 | 361.16 | 73.78 | 465.83 | 404.23 | Upgrade
|
Cash Growth | 15.15% | 389.52% | -84.16% | 15.24% | 323.54% | Upgrade
|
Accounts Receivable | 2,032 | 2,362 | 1,483 | 485.19 | 1,057 | Upgrade
|
Other Receivables | 3.87 | 118.59 | 171.14 | 182.27 | 169.67 | Upgrade
|
Receivables | 2,036 | 2,481 | 1,655 | 667.46 | 1,226 | Upgrade
|
Inventory | 2,847 | 2,337 | 2,235 | 2,511 | 1,378 | Upgrade
|
Prepaid Expenses | - | 52.54 | 49.33 | 33.07 | 22.18 | Upgrade
|
Other Current Assets | 245.32 | 107.35 | 93.78 | 93.17 | 62.54 | Upgrade
|
Total Current Assets | 5,545 | 5,339 | 4,106 | 3,771 | 3,093 | Upgrade
|
Property, Plant & Equipment | 5,655 | 4,649 | 4,437 | 4,476 | 4,625 | Upgrade
|
Long-Term Investments | 116.79 | 109.38 | 105.22 | 215.27 | 273.03 | Upgrade
|
Other Intangible Assets | 21.3 | 26.6 | 14.66 | 13.7 | 16.02 | Upgrade
|
Other Long-Term Assets | 188.85 | 217.3 | 132.32 | 119.28 | 114.74 | Upgrade
|
Total Assets | 11,527 | 10,341 | 8,796 | 8,595 | 8,122 | Upgrade
|
Accounts Payable | 1,139 | 1,513 | 1,074 | 649.92 | 549.54 | Upgrade
|
Accrued Expenses | - | 124.22 | 85.06 | 118.26 | 148.43 | Upgrade
|
Short-Term Debt | - | 1,140 | 937.89 | 679.12 | 708.59 | Upgrade
|
Current Portion of Long-Term Debt | 1,714 | 440.96 | 375.91 | 427 | 322.49 | Upgrade
|
Current Portion of Leases | - | 5.92 | 9.4 | 10.4 | 9.09 | Upgrade
|
Other Current Liabilities | 390.6 | 92.89 | 66.58 | 80.09 | 216.16 | Upgrade
|
Total Current Liabilities | 3,244 | 3,317 | 2,549 | 1,965 | 1,954 | Upgrade
|
Long-Term Debt | 1,394 | 1,221 | 1,211 | 1,495 | 1,474 | Upgrade
|
Long-Term Leases | - | - | 6.14 | 21.14 | 31.55 | Upgrade
|
Long-Term Deferred Tax Liabilities | 480.98 | 427.99 | 410.2 | 395.51 | 538.53 | Upgrade
|
Other Long-Term Liabilities | 12.07 | 7.82 | 6.01 | 5.73 | 5.82 | Upgrade
|
Total Liabilities | 5,130 | 4,978 | 4,191 | 3,892 | 4,017 | Upgrade
|
Common Stock | 88.65 | 84.65 | 84.65 | 84.65 | 84.65 | Upgrade
|
Additional Paid-In Capital | - | 698.18 | 698.18 | 698.18 | 698.18 | Upgrade
|
Retained Earnings | - | 4,279 | 3,807 | 3,905 | 3,307 | Upgrade
|
Comprehensive Income & Other | 6,308 | 301.25 | 15.5 | 15.5 | 15.5 | Upgrade
|
Total Common Equity | 6,396 | 5,363 | 4,605 | 4,703 | 4,105 | Upgrade
|
Minority Interest | 0 | - | - | - | - | Upgrade
|
Shareholders' Equity | 6,396 | 5,363 | 4,605 | 4,703 | 4,105 | Upgrade
|
Total Liabilities & Equity | 11,527 | 10,341 | 8,796 | 8,595 | 8,122 | Upgrade
|
Total Debt | 3,108 | 2,808 | 2,541 | 2,633 | 2,546 | Upgrade
|
Net Cash (Debt) | -2,692 | -2,447 | -2,467 | -2,167 | -2,142 | Upgrade
|
Net Cash Per Share | -31.77 | -28.90 | -29.14 | -25.60 | -25.30 | Upgrade
|
Filing Date Shares Outstanding | 84.65 | 84.65 | 84.65 | 84.65 | 84.65 | Upgrade
|
Total Common Shares Outstanding | 84.65 | 84.65 | 84.65 | 84.65 | 84.65 | Upgrade
|
Working Capital | 2,301 | 2,022 | 1,557 | 1,806 | 1,139 | Upgrade
|
Book Value Per Share | 75.57 | 63.36 | 54.40 | 55.56 | 48.50 | Upgrade
|
Tangible Book Value | 6,375 | 5,337 | 4,591 | 4,689 | 4,089 | Upgrade
|
Tangible Book Value Per Share | 75.32 | 63.04 | 54.23 | 55.39 | 48.31 | Upgrade
|
Land | - | 42.13 | 42.13 | 42.13 | 42.13 | Upgrade
|
Buildings | - | 1,341 | 1,308 | 1,300 | 1,233 | Upgrade
|
Machinery | - | 4,841 | 4,331 | 4,279 | 4,224 | Upgrade
|
Construction In Progress | - | 302.72 | 331.91 | 110.04 | 67.44 | Upgrade
|
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.